首页|期刊导航|山西中医药大学学报|基于网络药理学、分子对接技术及动物实验的苦参外治湿疹作用机制研究

基于网络药理学、分子对接技术及动物实验的苦参外治湿疹作用机制研究OA

Mechanism of Kushen external treatment for eczema based on network pharmacology molecular docking technology and animal experiments

中文摘要英文摘要

目的:利用网络药理学方法、分子对接技术及动物实验探讨苦参外治湿疹的作用机制.方法:借助TCMSP、GeneCards数据库筛选苦参有效成分、靶点及湿疹的疾病靶点,找出中药-疾病交集靶点,构建蛋白质-蛋白质互作(PPI)网络、"苦参-有效成分-湿疹靶点"网络,通过基因本体(GO)功能及京都基因与基因组百科全书(KEGG)通路富集分析,获得苦参外治湿疹的关键靶点及通路;对核心成分及关键靶点进行分子对接,建立小鼠湿疹模型,进一步验证苦参的抗炎作用.结果:苦参有效成分42个,关键成分4个,作用靶点177个,湿疹靶点3925个,交集靶点89个;PPI网络、"苦参-有效成分-湿疹"靶点网络综合分析显示,苦参外治湿疹机制与丝氨酸/苏氨酸激酶(Akt-1)、丝裂原活化蛋白激酶14(MAPK14)、白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)、白细胞介素-10(IL-10)等靶点有关;GO功能、KEGG通路富集分析得出IL-17、PI3K-Akt、NF-κB、JAK-STAT等多条通路可能在苦参外治湿疹中发挥作用;分子对接证实Akt1、IL-6与苦参核心成分均有较高的结合可能,且结合稳定性均较强;动物实验进一步证明苦参湿敷通过调节PI3K-Akt通路,降低湿疹模型小鼠血清促炎因子IL-1β、IL-6水平,升高抗炎因子IL-10水平,降低湿疹皮损炎症程度.结论:外用苦参可以通过多条受体信号通路、免疫通路作用于多种细胞因子、趋化因子,通过调节免疫和抑制炎症反应,改善湿疹皮损状态.

Objective:To investigate the mechanism of Kushen external treatment for eczema using network pharma-cology,molecular docking technology and animal experiments.Methods:The active components and targets of Kushen as well as eczema disease targets were screened using the TCMSP and GeneCards databases.Overlapping targets between the herb and the disease were identified.A protein-protein interaction(PPI)network and a"Kushen-active component-eczema target"network were constructed.Key targets and pathways involved in the Kushen external treatment for eczema were ob-tained through Gene Ontology(GO)functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis.Molecular docking was performed between core components and key targets.A mouse eczema model was established to further verify the anti-inflammatory effect of Kushen.Results:A total of 42 active components of Kushen were identified,including 4 key components,along with 177 targets of the herb,3925 eczema-related targets,and 89 overlapping targets.Comprehensive analysis of the PPI network and the"Kushen-active component-eczema"target net-work indicated that the mechanism of Kushen external treatment for eczema involved targets such as serine/threonine kinase(Akt-1),mitogen-activated protein kinase 14(MAPK14),interleukin-6(IL-6),interleukin-1β(IL-1β),and interleukin-10(IL-10).GO function and KEGG enrichment analyses revealed that multiple pathways,including IL-17,PI3K-Akt,NF-κB,and JAK-STAT,might play a role in the Kushen external treatment for eczema.Molecular docking confirmed that Akt1 and IL-6 had a high binding affinity and stable binding with the core components of Kushen.Animal experiments further demonstrated that wet compresses of Kushen reduced serum levels of pro-inflammatory factors IL-1β and IL-6,increased the level of anti-inflammatory factor IL-10,and alleviated the degree of skin inflammation in eczema model mice,likely through modulation of the PI3K-Akt pathway.Conclusion:External application of Kushen can act on multiple cytokines and chemokines through various receptor signaling pathways and immune pathways,thereby regulating immunity,suppressing inflammatory responses,and improving the skin lesion status in eczema.

王之佩;刘璐;田孝萍;王彰勇;梁丽丽

山西省汾阳医院皮肤性病科,山西 汾阳 032200山西省汾阳医院皮肤性病科,山西 汾阳 032200山西省汾阳医院皮肤性病科,山西 汾阳 032200山西省汾阳医院皮肤性病科,山西 汾阳 032200山西省人民医院皮肤性病科,山西 太原 030012

医药卫生

湿疹苦参网络药理学分子对接动物实验

eczemaKushennetwork pharmacologymolecular dockinganimal experiments

《山西中医药大学学报》 2026 (6)

616-625,10

山西省高等学校科技创新计划项目(2023L091)

10.19763/j.cnki.2096-7403.2026.06.20

评论